Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison Sells 25,000 Shares

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

R Dirk Allison also recently made the following trade(s):

• On Monday, November 25th, R Dirk Allison sold 12,500 shares of Addus HomeCare stock. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00.

Addus HomeCare Stock Up 0.3 %

Shares of Addus HomeCare stock traded up $0.33 during trading on Friday, hitting $124.59. The stock had a trading volume of 63,465 shares, compared to its average volume of 137,533. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.12. The stock has a 50 day simple moving average of $125.19 and a 200 day simple moving average of $125.70. The company has a market capitalization of $2.26 billion, a PE ratio of 28.51, a P/E/G ratio of 2.11 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.03 EPS. As a group, equities analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds have recently bought and sold shares of ADUS. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Addus HomeCare in the 3rd quarter worth approximately $1,622,000. Dimensional Fund Advisors LP increased its stake in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Victory Capital Management Inc. boosted its position in Addus HomeCare by 136.5% during the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock valued at $9,294,000 after purchasing an additional 46,199 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Addus HomeCare by 90.6% in the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock valued at $2,136,000 after purchasing an additional 8,743 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on ADUS shares. KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Buy” and an average price target of $133.67.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.